Direct conversion of human fibroblasts into functional osteoblasts by defined factors

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Molecular Biology

Background:

• Osteoblasts are crucial for bone formation and remodeling.
• Current bone regeneration therapies have limitations.

Purpose of the Study:

• To establish a direct reprogramming method to convert human fibroblasts into functional osteoblasts.
• To evaluate the potential of these converted osteoblasts for bone repair.

Main Methods:

• Fibroblast transduction with defined transcription factors: Runt-related transcription factor 2 (Runx2), Osterix, Octamer-binding transcription factor 3/4 (Oct4), and L-Myc (RXOL).
• Culture in osteogenic medium.
• Assessment of osteoblast markers, gene expression profiles, and in vivo bone repair capacity in immunodeficient mice.

Main Results:

• The RXOL combination successfully converted approximately 80% of fibroblasts into osteocalcin-producing cells (directly converted osteoblasts, dOBs).
• RXOL-induced dOBs exhibited gene expression profiles similar to normal human osteoblasts and expressed endogenous Runx2 and Osterix.
• Transplanted dOBs contributed to bone repair in artificial bone defects in mice.
• A combination of Oct4 and L-Myc (OL) also induced bone matrix production but resulted in cells with a less similar profile to osteoblasts and lacking Osterix expression.

Conclusions:

• Direct reprogramming of fibroblasts into functional osteoblasts is achievable using the RXOL factor combination.
• This method provides a potential new avenue for bone regeneration therapy.
• The generated osteoblasts maintain their phenotype without continuous exogenous gene expression.